HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology2 papers

Supranuclear gaze palsy

Last edited: 4/23/2026

Overview

Supranuclear gaze palsy involves impairment of eye movements due to lesions affecting areas above the ocular motor nuclei, typically resulting from stroke or neurodegenerative diseases 1.

Diagnosis

  • Fixed gaze deviation observed post-stroke or neurological insult 1.
  • Neuroimaging (MRI/CT) to identify cerebral hemisphere lesions 1.
  • Neurological examination focusing on voluntary and reflexive eye movements 1.
  • Vestibular function tests may help assess brainstem integrity 1.

    • Management

  • First-line treatments: Rehabilitation focusing on compensatory strategies and visual aids 1.
  • Adjunctive therapies: Vestibular stimulation (e.g., cold caloric stimulation) may offer transient improvement in some cases 1.

    • Special Populations

  • Elderly: Management focuses on supportive care and minimizing secondary complications 1.
  • No specific data on pediatrics or pregnancy from provided abstracts 1.

    • Key Recommendations

  • Consider vestibular stimulation techniques, such as cold caloric stimulation, as an adjunctive therapy for transient improvement in supranuclear gaze palsy symptoms (Evidence: Weak) 1.
  • Prioritize comprehensive neurological assessment including imaging to identify underlying cerebral lesions (Evidence: Expert opinion) 1.
  • Implement rehabilitation strategies tailored to compensate for gaze palsy and enhance functional independence (Evidence: Expert opinion) 1.

    • References

    1 Marshall CR, Maynard FM. Vestibular stimulation for supranuclear gaze palsy: case report. Archives of physical medicine and rehabilitation 1983. link

    Original source

    1. [1]
      Vestibular stimulation for supranuclear gaze palsy: case report. — Marshall CR, Maynard FM Archives of physical medicine and rehabilitation (1983)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG